Alcohol Consumption the Day of Liver Transplantation for Alcohol‐Associated Liver Disease Does Not Affect Long‐Term Survival: A Case‐Control Study

Archive ouverte

Ursic-Bedoya, José | Dumortier, Jérôme | Altwegg, Romain | Belkacemi, Mohamed | Vanlemmens, Claire | Dharancy, Sébastien | Besch, Camille | Shili-Masmoudi, Sarah | Francoz, Claire | Boillot, Olivier | Meszaros, Magdalena | Meunier, Lucy | Faure, Stéphanie | Herrero, Astrid | Donnadieu-Rigole, Hélène | Pageaux, Georges-Philippe

Edité par CCSD ; Wiley -

International audience. Alcohol abstinence before liver transplantation (LT) for alcohol-associated liver disease (ALD) is required for every candidate. Some listed patients might relapse, resulting in LT for patients nonabstinent during the pretransplant period. Long-term survival outcomes of these patients have never been studied. We sought to determine whether alcohol consumption on the day of the LT influenced long-term survival after LT. We conducted a retrospective case-control study among French LT centers. Cases were defined as recipients between January 1995 and December 2007 having positive blood and/or urine alcohol levels the day of LT. Each case was paired with 2 controls corresponding to patients transplanted for ALD during the same trimester. Patients were classified into 3 categories per alcohol consumption: abstainers, occasional or transitory excessive consumers, or patients with a sustained excessive consumption (daily consumption >20-30 g/day). During the study period, 3052 LTs for ALD were conducted in France. We identified 42 cases paired with 84 controls. Median blood alcohol level was 0.4 g/L (range 0.1-4.1 g/L) and median urine alcohol level was 0.2 g/L (range 0.1-2.0 g/L). Median follow-up period until death or censoring was 12.9 years (CI95% = [12.3; 13.6]). Long-term survival was not different between the groups. Relapse to any alcohol consumption rate was higher in the case group (59.5%) than in the control group (38.1%, odds ratio 2.44; CI95% = [1.13; 5.27]), but sustained excessive consumption was not significantly different between the groups (33.3% versus 29.8% in case and control groups respectively, χ2 = 0.68). Rates of recurrent cirrhosis and cirrhosis-related deaths were more frequent in the case group. Liver transplantation for nonabstinent patients during the immediate pretransplant period does not result in impaired long-term survival despite higher relapse and recurrent cirrhosis rates.

Consulter en ligne

Suggestions

Du même auteur

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

Archive ouverte | Villeret, François | CCSD

International audience. Background & aims: Liver transplantation (LT) is the only available treatment for end-stage non-alcoholic fatty liver disease (NAFLD) (related decompensated cirrhosis and/or hepatocellular ca...

Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse

Archive ouverte | Daniel, Jules | CCSD

International audience. Background & Aims : Liver transplantation (LT) is a last resort treatment for patients at high risk of mortality from end-stage liver disease. Over the past years, alcohol-associated liver di...

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival

Archive ouverte | Villeret, François | CCSD

International audience. Background and Aims: Liver transplantation (LT) is the treatment of end-stage nonalcoholic liver disease (NAFLD), that is decompensated cirrhosis and/or complicated by hepatocellular carcinom...

Chargement des enrichissements...